Zimmer Partners’s Enfusion, Inc. ENFN Stock Holding History

Zimmer Partners’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,000	Closed	-$419K	–	147
2021 Q4	$419K	Buy	+20,000	New	+$404K	0.01%	112

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ACM

Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Zimmer Partners's ENFN Position: Q1 2022 in Review

Zimmer Partners sold out of Enfusion, Inc. (ENFN) in Q1 2022, closing a stake of 20,000 shares — an estimated $419K sold.

Zimmer Partners first reported a position in ENFN in Q4 2021 and held it in 1 quarter. The position peaked at $419K in Q4 2021. 64 funds tracked by Wall St. Rank hold ENFN as of Q1 2022.

Zimmer Partners reported no remaining Enfusion, Inc. position as of Q1 2022 after selling out during the quarter.
Zimmer Partners sold 20,000 Enfusion, Inc. shares in Q1 2022, an estimated $419K.
Zimmer Partners first reported a position in Enfusion, Inc. in Q4 2021 and held it in 1 quarter.
Zimmer Partners's Enfusion, Inc. position peaked at $419K in Q4 2021.
64 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2022.

Based on Zimmer Partners's 13F filing for Q1 2022, filed 16 May 2022.